SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Antex Biologics (ANTX)
ANTX 1.100+2.3%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Christopher Horner who wrote (1085)12/15/1998 10:07:00 PM
From: Amigo Mike  Read Replies (1) of 1476
 
John - Chris,

Hi Guys !!!! Glad to you still around.

Antex is awaiting the trial results of the Phase II Campy from the chief investigator. Unfortunately, Antex is blinded from the results and cannot give information on the trial until the report is disclosed to them. IMO, the trial results are fine. No adverse problems. I suspect there may be a second quick Phase II to address any weakness there may be.

Not sure if Antex will put out a PR on it but they are receiving a $500K milestone payment from Pasteur this month. We might even get lucky and hear something about the Phase I H Influenzae. Pasteur unfortunately moves at there own pace. In the years Antex has been associated with Pasteur .... I think there has been two releases from Pasteur .... 1 to announce alliance and 1 to announce start of Phase I.

As to the price ..... well all I can say is my strategy is well known within the Antex family. IMO .... we are seeing some tax selling. Look at last year's chart. You will see similiar action. Then a nice pop in January. Keep in mind that Antex has ~.23 per share in cash on hand. With today's cloing price ..... subtracting the cash pert share.... the rest of Antex (technology, patents and alliances) is valued at about .15. Absolutely sickening.

Amigo Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News